FDA Issues Further Guidance About Makena
ST. LOUIS, July 2, 2012 /PRNewswire/ -- K-V Pharmaceutical Company (the "Company") (NYSE: KV.A/KV.B) today addressed the additional guidance provided by the U.S. Food and Drug Administration ...